Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Testosterone helps beard and axillary hair cells grow by releasing growth factors from dermal papilla cells.

New treatments for hair loss, like JAK inhibitors, PRP, anti-androgens, and minoxidil, offer better options.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Spironolactone plus finasteride reduces hirsutism more effectively.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Certain extracts from Curcuma aeruginosa Roxb. and germacrone can boost the skin's absorption of minoxidil, a hair growth promoter, making it more effective.

Testosterone increases hamster hair growth; cyproterone acetate reduces it.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

CBD may help reduce stress and pain in women with PCOS.

Severe hair loss is linked to worse COVID-19 outcomes, especially in younger men.

New drug shows promise for better hair growth in baldness treatment.

Most women with excess hair growth need only a clinical evaluation and minimal tests unless they show signs of virilism.